Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 03, 2019 16:05 ET
|
Karyopharm Therapeutics Inc.
NEWTON, Mass., June 03, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company, today announced that the Compensation Committee of Karyopharm’s...
Karyopharm to Participate in Upcoming Investor Conferences
May 28, 2019 07:00 ET
|
Karyopharm Therapeutics Inc.
NEWTON, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, announced today that the Company’s management team will...
Karyopharm Announces Results of Clinical Studies Investigating Selinexor to be Presented at the European Hematology Association 2019 Annual Meeting
May 16, 2019 11:06 ET
|
Karyopharm Therapeutics Inc.
-- Oral Presentation Highlighting Updated Data from the Phase 1b/2 STOMP Study Arm Evaluating Selinexor and Dexamethasone in Combination with Darzalex® in Patients with Relapsed or Refractory Multiple...
Karyopharm’s Founder Sharon Shacham, PhD, Receives NYIPLA Inventor of the Year Award
May 15, 2019 07:00 ET
|
Karyopharm Therapeutics Inc.
NEWTON, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, congratulates its founder, President and Chief Scientific...
Karyopharm Reports First Quarter 2019 Financial Results and Highlights Recent Company Progress
May 09, 2019 07:02 ET
|
Karyopharm Therapeutics Inc.
-- FDA Extends Review Period for Selinexor New Drug Application to July 6, 2019 -- -- Selinexor MAA Validated in Europe; Approval Decision Expected by End of 2019 -- -- Conference Call Scheduled...
Karyopharm to Participate in Upcoming Investor Conferences
May 08, 2019 07:00 ET
|
Karyopharm Therapeutics Inc.
NEWTON, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, announced today that the Company’s management team will...
Karyopharm to Report First Quarter 2019 Financial Results on May 9, 2019
May 02, 2019 07:00 ET
|
Karyopharm Therapeutics Inc.
-- Conference Call Scheduled for Thursday, May 9, 2019 at 8:30 a.m. ET -- NEWTON, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical...
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 01, 2019 16:05 ET
|
Karyopharm Therapeutics Inc.
NEWTON, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company, today announced that the Compensation Committee of Karyopharm’s...
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 01, 2019 16:05 ET
|
Karyopharm Therapeutics Inc.
NEWTON, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company, today announced that the Compensation Committee of...
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 28, 2019 16:51 ET
|
Karyopharm Therapeutics Inc.
NEWTON, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company, today announced that it has granted stock options to Michael P....